Avalon GloboCare Joins AMD AI Program and Renews FDA Registration for KetoAir
Avalon GloboCare has joined AMD's AI Developer Program to gain cloud credits, advanced development tools and high-performance computing with Instinct accelerators and EPYC processors for its AQAI subsidiary's AI video generation and workflow automation. Avalon renewed FDA registration for its KetoAir breathalyzer and plans marketing in Q2 2026.
1. AMD AI Developer Program Partnership
Avalon GloboCare joined the AMD AI Developer Program, gaining access to cloud credits, advanced development tools and community resources to accelerate its AI initiatives. The program provides high-performance computing powered by AMD Instinct accelerators and EPYC processors, aiming to boost model training efficiency and speed inference for large language and multimodal AI systems.
2. AQAI Platform Applications
Avalon Quantum AI LLC will leverage AMD resources to scale its automated commentary video generation systems, develop enterprise-grade documentation tools and build an AI-powered workflow automation platform. These enhancements are designed to compress development timelines and support scalable AI solutions for corporate communications and adaptive content creation.
3. KetoAir FDA Renewal and Commercial Plans
In January, Avalon renewed its FDA establishment registration for KetoAir, a handheld breathalyzer that measures breath acetone concentration using nano-sensor technology. The device will integrate with iOS and Android apps, with B2B and B2C marketing initiatives slated to begin in the second quarter of 2026.